top of page


Zealand Pharma signs AI protein therapeutics collaboration with Generate Biomedicines worth over $1 billion
Zealand Pharma and Generate Biomedicines have signed an AI-enabled protein therapeutics collaboration for obesity and metabolic diseases with potential milestone payments approaching $1.2 billion.

nuaxia
Oct 152 min read


FDA seeks public feedback on regulatory approach for generative AI-enabled medical devices
The discussion paper launches a public consultation that could shape future regulatory expectations for AI-enabled medical devices, including premarket evaluation, risk assessment and postmarket monitoring.

nuaxia
Aug 202 min read
bottom of page